| Ewa H Schafer, MD | |
|
2150 Pfingsten Rd, Glenview, IL 60026-1361 | |
| (847) 570-2431 | |
| (847) 733-5109 |
| Full Name | Ewa H Schafer |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 22 Years |
| Location | 2150 Pfingsten Rd, Glenview, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053436345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | 036112175 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Swedish Covenant Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore University Healthsystem Faculty Practice Associates | 2163334699 | 1751 |
News Archive
The Journal of Rehabilitation Research and Development (JRRD) today released a single-topic issue on traumatic brain injury (TBI) and polytrauma.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
About 450,000 children, displaced by severe flooding in the southern Philippines, could face an outbreak of diarrhea and pneumonia, Vanessa Tobin, UNICEF's representative in the Philippines, said on Sunday, Agence France-Presse reports.
One in five participants were without treatment for 4 years before, during and after pregnancy. Over 9 000 people live with familial hypercholesterolemia (FH) in Norway, but another 16 000 people may have hereditary high cholesterol without knowing it.
› Verified 4 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
The Journal of Rehabilitation Research and Development (JRRD) today released a single-topic issue on traumatic brain injury (TBI) and polytrauma.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
About 450,000 children, displaced by severe flooding in the southern Philippines, could face an outbreak of diarrhea and pneumonia, Vanessa Tobin, UNICEF's representative in the Philippines, said on Sunday, Agence France-Presse reports.
One in five participants were without treatment for 4 years before, during and after pregnancy. Over 9 000 people live with familial hypercholesterolemia (FH) in Norway, but another 16 000 people may have hereditary high cholesterol without knowing it.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ewa H Schafer, MD 2050 Pfingsten Rd, Suite 320, Glenview, IL 60026-1324 Ph: (847) 998-4170 | Ewa H Schafer, MD 2150 Pfingsten Rd, Glenview, IL 60026-1361 Ph: (847) 570-2431 |
News Archive
The Journal of Rehabilitation Research and Development (JRRD) today released a single-topic issue on traumatic brain injury (TBI) and polytrauma.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
About 450,000 children, displaced by severe flooding in the southern Philippines, could face an outbreak of diarrhea and pneumonia, Vanessa Tobin, UNICEF's representative in the Philippines, said on Sunday, Agence France-Presse reports.
One in five participants were without treatment for 4 years before, during and after pregnancy. Over 9 000 people live with familial hypercholesterolemia (FH) in Norway, but another 16 000 people may have hereditary high cholesterol without knowing it.
› Verified 4 days ago
Evelyn Lizbeth Angulo, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2050 Pfingsten Rd Ste 320, Glenview, IL 60026 Phone: 847-998-4170 Fax: 847-998-4165 | |
J Keith Lemmon, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3633 W Lake Ave, Suite 412, Glenview, IL 60026 Phone: 847-657-6060 Fax: 847-657-7070 | |
Dr. Yasmeen S Bilimoria, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 2550 Compass Rd, Unit K, Glenview, IL 60026 Phone: 847-832-6000 Fax: 847-832-1900 |